Published by Josh White on 3rd September 2020
(Sharecast News) - Biotechnology company Allergy Therapeutics announced further investment in virus-like particle (VLP) technology for applications beyond the allergy immunotherapy field on Thursday.
URL: http://www.digitallook.com/dl/news/story/31133968/...